• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI Executive AssistantNEW
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI Executive AssistantNEW
  • Settings
  • RSS Feeds
PublishGo to AppAI Helper
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI employees for your businessNEW
    Legal
    Terms of usePrivacy policyCookie policy

    Needham initiated coverage on Omada Health with a new price target

    7/1/25 8:21:11 AM ET
    $OMDA
    Medical/Nursing Services
    Health Care
    Get the next $OMDA alert in real time by email
    Needham initiated coverage of Omada Health with a rating of Buy and set a new price target of $23.00
    Get the next $OMDA alert in real time by email

    Crush Q3 2025 with the Best AI Executive Assistant

    Stay ahead of the competition with Tailforce.ai - your AI-powered business intelligence partner.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Tailforce.ai

    Recent Analyst Ratings for
    $OMDA

    DatePrice TargetRatingAnalyst
    7/1/2025$21.00Outperform
    Evercore ISI
    7/1/2025$25.00Overweight
    Morgan Stanley
    7/1/2025$19.00Overweight
    Analyst
    7/1/2025$23.00Buy
    Needham
    7/1/2025$21.00Overweight
    Barclays
    7/1/2025$29.00Buy
    Goldman
    7/1/2025$27.00Buy
    Canaccord Genuity
    More analyst ratings

    $OMDA
    SEC Filings

    See more
    • SEC Form 8-K filed by Omada Health Inc.

      8-K - Omada Health, Inc. (0001611115) (Filer)

      6/9/25 4:05:24 PM ET
      $OMDA
      Medical/Nursing Services
      Health Care
    • SEC Form 424B4 filed by Omada Health Inc.

      424B4 - Omada Health, Inc. (0001611115) (Filer)

      6/9/25 6:07:31 AM ET
      $OMDA
      Medical/Nursing Services
      Health Care

    $OMDA
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • Large owner Revelation Alpine, Llc converted options into 4,181,664 shares (SEC Form 4)

      4 - Omada Health, Inc. (0001611115) (Issuer)

      6/9/25 5:22:16 PM ET
      $OMDA
      Medical/Nursing Services
      Health Care
    • Large owner Revelation Alpine, Llc converted options into 4,181,664 shares (SEC Form 4)

      4 - Omada Health, Inc. (0001611115) (Issuer)

      6/9/25 5:13:11 PM ET
      $OMDA
      Medical/Nursing Services
      Health Care
    • Director Root Jonathan D was granted 9,736 shares and converted options into 4,684,659 shares (SEC Form 4)

      4 - Omada Health, Inc. (0001611115) (Issuer)

      6/9/25 4:20:57 PM ET
      $OMDA
      Medical/Nursing Services
      Health Care

    $OMDA
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    See more

    $OMDA
    Press Releases

    Fastest customizable press release news feed in the world

    See more
    • Evercore ISI initiated coverage on Omada Health with a new price target

      Evercore ISI initiated coverage of Omada Health with a rating of Outperform and set a new price target of $21.00

      7/1/25 8:41:36 AM ET
      $OMDA
      Medical/Nursing Services
      Health Care
    • Morgan Stanley initiated coverage on Omada Health with a new price target

      Morgan Stanley initiated coverage of Omada Health with a rating of Overweight and set a new price target of $25.00

      7/1/25 8:21:32 AM ET
      $OMDA
      Medical/Nursing Services
      Health Care
    • Analyst initiated coverage on Omada Health with a new price target

      Analyst initiated coverage of Omada Health with a rating of Overweight and set a new price target of $19.00

      7/1/25 8:21:32 AM ET
      $OMDA
      Medical/Nursing Services
      Health Care
    • Omada Health's Enhanced GLP-1 Care Track Demonstrates Increased Medication Persistence and Weight Loss Outcomes at 12 and 24 Weeks

      SAN FRANCISCO, June 17, 2025 (GLOBE NEWSWIRE) -- Omada Health (NASDAQ:OMDA), the virtual between-visit healthcare provider, released new data1 demonstrating that Omada's GLP-1 companion program significantly improved persistence rates for GLP-1 medications. Evidence suggests that persistence on a GLP-1 is associated with greater weight loss.2 Omada's analysis found that those who persisted with their GLP-1 medication achieved weight loss results similar to what has been found in controlled research settings.1 Despite a growing body of evidence supporting vast clinical benefits of GLP-1s,3 while results vary widely, one study showed that one-third of people stopped taking their GLP-1 in

      6/17/25 9:00:00 AM ET
      $OMDA
      Medical/Nursing Services
      Health Care
    • Smart Healthcare Is Taking Over. Here's Where the Money's Headed

      Issued on behalf of Avant Technologies Inc.Equity Insider News Commentary VANCOUVER, BC, June 10, 2025 /PRNewswire/ -- Both politicians and leaders in academia are touting the AI revolution empowering the frontline of what's dubbed Smart Healthcare. In a recent write-up in Forbes, Prof. Nicos Savva of the London Business School cited recent speeches from former British Prime Minister Tony Blair, who insists that the UK needs to embrace a future with AI doctors and nurses, or risk being left behind. A new report from Wolters Kluwer has experts calling for more clarity around its use, adoption, and business strategy, because most healthcare organizations aren't currently ready to use GenAI too

      6/10/25 11:13:00 AM ET
      $AMZN
      $GOOG
      $GOOGL
      $OMDA
      Catalog/Specialty Distribution
      Consumer Discretionary
      Computer Software: Programming Data Processing
      Technology

    $OMDA
    Leadership Updates

    Live Leadership Updates

    See more
    • Omada Health's Enhanced GLP-1 Care Track Demonstrates Increased Medication Persistence and Weight Loss Outcomes at 12 and 24 Weeks

      SAN FRANCISCO, June 17, 2025 (GLOBE NEWSWIRE) -- Omada Health (NASDAQ:OMDA), the virtual between-visit healthcare provider, released new data1 demonstrating that Omada's GLP-1 companion program significantly improved persistence rates for GLP-1 medications. Evidence suggests that persistence on a GLP-1 is associated with greater weight loss.2 Omada's analysis found that those who persisted with their GLP-1 medication achieved weight loss results similar to what has been found in controlled research settings.1 Despite a growing body of evidence supporting vast clinical benefits of GLP-1s,3 while results vary widely, one study showed that one-third of people stopped taking their GLP-1 in

      6/17/25 9:00:00 AM ET
      $OMDA
      Medical/Nursing Services
      Health Care